National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

erythromycin
A broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:E-Mycin
ERYC
Ery-Tab
Ilotycin
Robimycin
RP-Mycin



Previous:erlotinib hydrochloride, ertapenem sodium, ertumaxomab, Ery-Tab, ERYC
Next:erythromycin topical cream, escitalopram oxalate, Eskalith, esomeprazole magnesium, esorubicin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov